169352 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
Collagen IV binding assay for the detection of collagen VII
#302Apparatus for detecting analyte in a liquid sample and method thereof
#303Universal assay for determining the quantity of TNFα inhibitory drugs and their corresponding anti-drug-antibodies
#304Early marker of proteinuria in patients treated with an anti-VEGF treatment
#305SPECIFIC DETECTION OF RAT ANTIBODIES IN MOUSE SERUM
#306Allergen dosage form
#307Conjugates for assays for oxycodone and oxymorphone
#308Microfluidic device
#309METHODS OF MONITORING ADHERENCE TO QUETIAPINE THERAPY
#310Quinolinium conjugates of cyclosporin
#311Antibodies to olanzapine haptens and use thereof
#312Indirect homogeneous mobility shift assays for the detection of biologics in patient samples
#313Methods and dose packs for monitoring medication adherence
#314MULTIPLEXED TOTAL ANTIBODY AND ANTIBODY-CONJUGATED DRUG QUANTIFICATION ASSAY
#315Method for measuring anti-drug antibody
#316Methods for prediction of anti-TNFα drug levels and autoantibody formation
#317Multisignal reagents for labeling analytes
#318Antibodies to risperidone and use thereof
#319VITELLINE MEMBRANE AS A MODEL OF THE BLOOD BRAIN BARRIER
#320ANTIBODIES TO PALIPERIDONE HAPTENS AND USE THEREOF
#321METHODS OF MONITORING FOR ADHERENCE TO BREXPIPRAZOLE (REXULTI®) THERAPY
#322Methods and apparatus for detecting compounds in liquids
#323INTEGRATED DEVICE FOR ANALYTE TESTING, CONFIRMATION, AND DONOR IDENTITY VERIFICATION
#324Method for the direct detection and/or quantification of at least one compound with a molecular weight of at least 200
#325Desmoglein 2 (DSG2) binding proteins and uses therefor
#326METHODS AND APPARATUS FOR DETECTING COMPOUNDS IN LIQUIDS
#327Antibodies to olanzapine haptens and use thereof
#328Modulation of the VPS10p-Domain Receptor Family for the Treatment of Mental and Behavioural Disorders
#329Lateral flow immunoassays for the detection of antibodies against biological drugs
#330Automated ultra-filtration workstation
#331Antibodies to aripiprazole haptens and use thereof
#332Self-administered tamper-evident drug detection
#333METHODS OF MONITORING ADHERENCE TO LURASIDONE THERAPY
#334Method for pretreatment and method for analysis of lenalidomide in biological sample
#335Metabolic biomarkers of autism
#3365-ALA FOR DETECTION OF BRAIN TUMORS
#337READY-TO-CONSTITUTE ANALYTICAL PLATFORMS FOR CHEMICAL ANALYSES AND QUANTIFICATION
#338DIAGNOSIS AND TREATMENT METHODS FOR ENTRY OF GASTROINTESTINAL CONTENTS INTO RESPIRATORY TRACT
#339Antibodies to quetiapine and use thereof
#340Antibodies to risperidone and use thereof
#341Identifying illicit drugs and their metabolites using a portable electroanalytical system
#342Method for quantitatively measuring the concentration of a compound of unknown concentration in protein samples
#343Piericidin bacterial inhibitors
#344Optimization and Individualization of Medication Selection and Dosing
#345RP-HPLC analysis of complex polypeptide mixtures
#346System And Method For Measuring Permeability Of Drugs/Toxic/Chemical Compounds
#347Antibodies to paliperidone haptens and use thereof
#348Chemical assay to verify the quantity and quality of sesquiterpene lactone derivatives
#349Small molecule detection and localization method based on MALDI imaging mass spectrometry
#350Antibody-based affinity reagents for binding paclitaxel
#351Anti-pembrolizumab antibodies
#352Methods for detecting and/or measuring anti-drug antibodies, in particular treatment-emergent anti-drug antibodies
#353Methods of detecting biological prints, fluids or analytes therein using porous semiconductor substrates
#354ISOTOPIC IDENTIFICATION AND TRACING OF BIOLOGIC PRODUCTS
#355Antibodies to olanzapine and use thereof
#356Antibodies to aripiprazole and use thereof
#357Maribavir isomers, compositions, methods of making and methods of using
#358Quantitation of tamoxifen and metabolites thereof by mass spectrometry
#359PHARMACEUTICAL FORM FOR COMBATING CHEMICAL SUBMISSION OF A MEDICAMENT
#360Modular point-of-care devices, systems, and uses thereof
#361Modular point-of-care devices, systems, and uses thereof
#362Assay for methoxetamine
#363Analytical devices for detection of low-quality pharmaceuticals
#364Rapid and sensitive method of forensic toxicology in post-mortem subjects using oral fluid testing
#365Method for detecting small molecules in a sample
#366SYSTEMS AND METHODS FOR COMBINED VERTICAL/LATERAL FLOW BLOOD SEPARATION TECHNOLOGIES WITH ENABLEMENT OF POINT-OF-CARE COTININE DETECTION WITH EXTENDED RANGE
#367DRUG MONITORING AND REGULATION SYSTEMS AND METHODS
#368Antibodies to quetiapine and use thereof
#369Knock-in rodent comprising a mutation in an endogenous CRBN locus and methods of use thereof
#370ANALYSIS OF ANTIBODIES
#371Allergen dosage form
#372SKIN MODEL
#373Anti-inflammatory compounds
#374Optimizing mifepristone levels for cushing's patients
#375PORTABLE CHEMICAL TESTING APPARATUS, SYSTEM, AND METHOD
#376COMPOSITIONS AND METHODS FOR SELECTING A TREATMENT FOR B-CELL NEOPLASIAS
#377Anti-VLA-4 related assays
#378Modular point-of-care devices, systems, and uses thereof
#379Modular point-of-care devices, systems, and uses thereof
#380Alzheimer's disease assay in a living patient
#381Specific Detection of Rat Antibodies in Mouse Serum
#382Modular point-of-care devices, systems, and uses thereof
#383Small molecule-dependent split aptamer ligation
#384BIOMOLECULAR INTERACTION DETECTION DEVICES AND METHODS
#385Testing device for testing analytes in liquid samples
#386Method of modulating the activity of a nucleic acid molecule
#387Fabric phase sorptive extractors
#388Systems and methods for distinguishing cotinine from anabasine in a point-of-care testing device
#389Method for In Vitro Quantifying Allo-Antibodies, Auto-Antibodies and/or Therapeutic Antibodies
#390Methods of treatment of HSCT-associated thrombotic microangiopathy with eculizumab
#391MARIBAVIR ISOMERS, COMPOSITIONS, METHODS OF MAKING AND METHODS OF USING
#392Simultaneous Assay of Target and Target-Drug Binding
#393MODULAR POINT-OF-CARE DEVICES, SYSTEMS, AND USES THEREOF
#394Drug target capturing method
#395Methods for detecting antibodies
#396COMPOSITION, FORMULATIONS AND METHODS OF MAKING AND USING BOTANICALS AND NATURAL COMPOUNDS FOR THE PROMOTION OF HEALTHY BRAIN AGING
#397Modular point-of-care devices, systems, and uses thereof
#398Mechanism and drug targets for reducing cell edema (neuroprotection) and cytoplasmic excitability in astrocytes in normal and pathological states
#399VISUALIZED BIOCHIP AND METHOD FOR SIMULTANEOUSLY DETECTING A VARIETY OF ANTIBIOTICS, ILLEGAL ADDITIVES AND BIOTOXINS
#400Single domain antibodies directed against STAT3
#401Single domain antibodies directed against KRAS
#402Single domain antibodies directed against TNF-alpha
#403Immunoassay for pyrrolidinophenones
#404Specific detection of rat antibodies in mouse serum
#405PORTABLE TESTING SYSTEM FOR DETECTING SELECTED DRUGS OR COMPOUNDS IN NONCONTROLLED ENVIRONMENTS
#406MODULATORS OF PHARMACOKINETIC PROPERTIES OF THERAPEUTICS
#407Mass spectrometric quantitation for metabolites of leflunomide
#408Early marker of proteinuria in patients treated with an anti-VEGF treatment
#409METHODS OF MONITORING ADHERENCE TO QUETIAPINE THERAPY
#410Aminoheteroaryl compounds as MTH1 inhibitors
#411Collagen IV binding assay for the detection of collagen VII
#412METHODS TO PREDICT AND PREVENT RESISTANCE TO TAXOID COMPOUNDS
#413METHODS AND SYSTEMS FOR DETECTING POLYPHARMACY
#414Skin model
#415Active Agent Prodrugs with Heterocyclic Linkers
#416Modular point-of-care devices, systems, and uses thereof
#417Modular point-of-care devices, systems, and uses thereof
#418Modular point-of-care devices, systems, and uses thereof
#419Immunoassay for compounds of the NBOMe family
#420Quantitation of tamoxifen and metabolites thereof by mass spectrometry
#421METHODS FOR ASSESSING IMMUNOGENICITY
#422In vitro release assay for liposome encapsulated vincristine
#423LATERAL FLOW IMMUNOASSAY
#424Methods, devices, and reagents for monitoring paclitaxel concentration in plasma for pharmacokinetic-guided dosing of paclitaxel
#425Methods for detecting antibodies
#426NEW AZIDES, METHOD FOR PRODUCING SAME AND APPLICATIONS THEREOF
#427INHALATION SENSOR FOR ALTERNATIVE NICOTINE/THC DELIVERY DEVICE
#428Automated ultra-filtration apparatus
#429Test swipe for portable explosive or drug detection system
#430SYSTEM FOR SECURING A CHAIN OF CUSTODY OF A SPECIMEN OF A DONOR
#431Assays for detecting the presence or amount of an anti-drug antibody
#432Enzyme-linked immunosorbent assay kit for detecting dinitolmide and use thereof
#433Method for the direct detection and/or quantification of at least one compound with a molecular weight of at least 200
#434Test kit for the quantitative determination of narcotic drugs
#435PULSE-BURST ASSISTED ELECTROSPRAY IONIZATION MASS SPECTROMETER
#436Device for collecting and testing analyte in a liquid sample
#437PIEZOELECTRIC SYSTEM FOR PORTABLE EXPLOSIVE OR DRUG DETECTION
#438Diagnosis of entry of gastrointestinal contents into respiratory tract of humans and animals
#439Methods of monitoring adherence to lurasidone therapy
#440Trapping reagents for reactive metabolites screening
#441INTEGRATED DEVICE FOR ANALYTE TESTING, CONFIRMATION, AND DONOR IDENTITY VERIFICATION
#442Clinical diagnostic systems
#443Multiplexed chromatography-immunoassay method for the characterization of circulating immune complexes
#444Encoded microcapsules and microarray fabricated therefrom
#445GEMCITABINE IMMUNOASSAY
#446Human control antibodies and uses therefor
#447Assays, antibodies, immunogens and compositions related to 5-FU
#448BIORELEVANT COMPOSITIONS
#449GENETICALLY MODIFIED RAT MODELS FOR PHARMACOKINETICS
#450Method of dynamic spectroscopy under physiological conditions
#451Drug simulant recognition system and method of employing
#452Immunoassay for phenethylamines of the 2C and DO sub-families
#453Microfluidic platform and methods for using the same
#454COLORIMETRIC METHOD TO DETECT ILLICIT DRUGS
#455Assay, composition and non-enzymatic mechanism of statin in modulating lipid metabolism
#456Catalytic Tagging System to Study Macro-Molecular Interactions Using Engineered Ubiquitin Ligase and Ubiquitin-Like Proteins to Facilitate Substrate Identification
#457Simultaneous Assay of Target and Target-Drug Binding
#458METHODS AND COMPOSITIONS FOR THERAPEUTIC DRUG MONITORING AND DOSING BY POINT OF CARE PHARMACOKINETIC PROFILING
#459System for determining unprocessed and partially processed neurotoxin type A
#460Antibody specific for trans-resveratrol and use thereof
#461VERIFYING THE SOURCE OF BIOLOGICAL SAMPLES; METHOD, COMPOSITION AND KIT THEREFOR
#462Anti-inflammatory compounds
#463Method of detecting and/or quantifying an analyte in a biological sample
#464Method for determining degree of modified potency of a medicament
#465Microfluidic analyte detection cartridge device, system and method
#466Modulation of the VPS10p-domain receptor family for the treatment of mental and behavioural disorders
#467Detection of membrane protein-therapeutic agent complexes by mass spectrometry
#468Devices and methods for the collection and detection of substances
#469Deuterium free, stable isotope labeled 2-phenylethylamine hallucinogens and/or stimulants, methods of their preparation and their use
#470Posaconazole immunoassays
#471Method for rapidly measuring melatonin adulteration of Chinese patent medicine or healthcare food
#472Diagnosis and treatment methods for entry of gastrointestinal contents into respiratory tract
#473Recognition of cellular target binding by a bioactive agent using intracellular bioluminescence resonance energy transfer
#474Glutathione alkylester isotopologue and method for detecting reactive metabolite
#475VERSATILE DRUG TESTING DEVICE
#476Coupled heterogeneous devices for pH sensing
#477Use of fluorescent saccharide-based derivative
#478Immunoassays for meperidine and metabolites
#479Screening for neurotoxic amino acid associated with neurological disorders
#480Antibodies to quetiapine and use thereof
#481Antibodies to quetiapine haptens and use thereof
#482Antibodies to olanzapine and use thereof
#483Antibodies to Olanzapine Haptens and Use Thereof
#484Antibodies to risperidone and use thereof
#485Antibodies to risperidone haptens and use thereof
#486Antibodies to aripiprazole and use thereof
#487Antibodies to aripiprazole haptens and use thereof
#488Antibodies to Paliperidone Haptens and Use Thereof
#489Complex in which anti-cotinine antibody is bound to conjugate of cotinine and binding substance, and use thereof
#490Preparation of anti-PEG antibody expressing cell and application thereof
#491Direct reading detection kits for surface contamination by antineoplastic drugs
#492Alzheimer's disease assay in a living patient
#493Alzheimer's disease assay in a living patient
#494Methods for determining anti-drug antibody isotypes
#495Risk assessment for adverse drug reactions
#496Capillary electrophoresis method for fine structural analysis of enoxaparin sodium
#497Early marker of proteinuria in patients treated with an anti-VEGF treatment
#498Nicotinamide phosphoribosyltransferase (NMPRTase) inhibitor for glioma therapy
#499COMPOUNDS AND METHODS OF MODULATING MITOCHONDRIAL BIOENERGETIC EFFICIENCY THROUGH AN INTERACTION WITH ATP SYNTHASE (COMPLEX V) AND ITS SUBUNITS
#500Method of securing a chain of custody of a specimen of a donor
#501Daikenchuto bioassay method and quality management method using same
#502Red blood cell dynamics for administering treatment for iron-deficiency anemia
#503Treating attention deficit hyperactivity disorder with NHE inhibitors
#504IMMUNOASSAY FOR PYRROLIDINOPHENONES
#505Composition and methods for treating glioblastoma
#506Detection of nicotine metabolites
#507Substance detecting apparatus
#508Multisensor array for detection of analytes or mixtures thereof in gas or liquid phase
#509DRUG SUSCEPTIBILITY USING RARE CELL DETECTION SYSTEM
#510DENTINAL DRUG DELIVERY COMPOSITION AND SCREENING METHOD
#511Multisignal reagents for labeling analytes
#512EARLY MARKER OF PROTEINURIA IN PATIENTS TREATED WITH AN ANTI-VEGF TREATMENT
#513Methods to predict and prevent resistance to taxoid compounds
#514In vitro assay for quantifying clostridial neurotoxin activity
#515Clozapine immunoassay
#516CLOZAPINE IMMUNOASSAY
#517Gemcitabine immunoassay
#518Gemcitabine immunoassay
#519System for automatically testing a fluid specimen
#520Maribavir isomers, compositions, methods of making and methods of using
#521ASSAY FOR QUANTIFYING CLOSTRIDIAL NEUROTOXIN
#522Anti-VLA-4 related assays
#523CROSS-LINKING ATP ANALOGS
#524Modulators of pharmacokinetic properties of therapeutics
#525Lipophilic dye-based FRET assays for clostridial toxin activity
#526Stabilized standards for busulfan immunoassay
#527Method and system for detecting residual poison in human body
#528Distinguishing assay
#529PHENOXYBENZAMINE ASSAY
#530DOXORUBICIN IMMUNOASSAY
#531System for determining unprocessed and partially processed neurotoxin type A
#532METHODS OF OPTIMIZING DRUG THERAPEUTIC EFFICACY FOR TREATMENT OF IMMUNE-MEDIATED GASTROINTESTINAL DISORDERS
#533Molecule biomarkers of autism
#534Mass spectrometric quantitation assay for metabolites of leflunomide
#535SYSTEM AND METHOD FOR DETECTION OF A CONTAMINATED BEVERAGE
#536Modular point-of-care devices, systems, and uses thereof
#537Method of identifying patients not suitable for high-dose cyclophosphamide treatment
#538FOLATE-TARGETED DIAGNOSTICS AND TREATMENT
#539BRM Expression and Related Diagnostics
#540Drug monitoring assay
#541TEST SWIPE FOR PORTABLE EXPLOSIVE OR DRUG DETECTION SYSTEM
#542Assay system for determining binding of hydrophobic drugs
#543Risk Assessment For Adverse Drug Reactions
#544Risperidone immunoassay
#545Modulation of the Vps10p-domain receptor family for the treatment of mental and behavioural disorders
#546Lyophilised dabigatran
#547TRAPPING COMPOUNDS AND METHOD FOR IDENTIFYING REACTIVE METABOLITES
#548DOXORUBICIN IMMUNOASSAY
#549ANTI-POLYETHYLENE GLYCOL ANTIBODY EXPRESSING CELL QUANTIFY ANY FREE POLYETHYLENE GLYCOL AND POLYETHYLENE GLYCOL-DERIVATIZED MOLECULES
#550Hydrophobic silica particles and methods of making same
#551EVALUATING RENAL FUNCTION
#552Diagnosis of entry of gastrointestinal contents into respiratory tract of humans and animals
#553Risk assessment for cutaneous adverse drug reactions from antiretroviral agent
#554NEUROACTIVE STEROID COMPOSITIONS AND METHODS OF USE THEREFOR
#555METHOD FOR QUANTIFICATION OF BODY INTERNAL CONCENTRATION OF PROTEIN-BASED DRUG
#556TARGET PROTEIN AND TARGET GENE FOR DRUG DISCOVERY, AND SCREENING METHOD
#557INDIVIDUAL 5-FLUOROURACILE DOSE OPTIMIZATION IN FOLFOX TREATMENT
#558Risperidone immunoassay
#559Assay for analysis of free drug in samples
#560Method for automatically testing a fluid specimen
#561Simultaneous assay for determining drugs
#562Screening for neurotoxic amino acid associated with neurological disorders
#563Screening Method (Metabolite Grid) for Therapeutic Extracts and Molecules for Diabetes
#564Genetically Modified Rat Models for Pharmacokinetics
#565Integrated device for analyte testing, confirmation, and donor identity verification
#566DETERMINATION OF FREE FRACTIONS
#567Methods for detecting antibodies
#568Solid phase multi-analyte assay
#569Method for improving the properties of a drug lead compound
#570Multimeric tie 2 agonists and uses thereof in stimulating angiogenesis
#571METHOD AND DEVICE FOR MONITORING MEDICATION USAGE
#572Methods of distinguishing between glutamine formed by cataplerosis or proteolysis
#573Probes, Systems, and Methods for Drug Discovery
#574Genetically Modified Rat Models for Drug Metabolism
#575Method of assaying 5-FU
#576Cell-enzyme based biosensors
#577Distinguishing assay
#578Colorimetric test for antimalarial artemesin derivatives
#579Salvinorin immunoassay
#580NOVEL CHROMATOGRAPHY METHODS
#581Bioequivalence evaluation method of evaluating bioequivalence of a generic drug to the corresponding original drug
#582Portable tester for detection explosives, drugs and chemicals based on created color bar codes for analytes
#583NOVEL PHARMACEUTICAL COMPOSITIONS AND METHODS OF PREPARATION AND USE
#584TREATMENT FOR DRUG ADDICTION
#585Site selectively tagged and templated molecularly imprinted polymers for sensor applications
#586METHODS OF DETERMINING ACTIVE LEVELS OF DRUGS IN FLUID SAMPLES
#587Drug monitoring assay
#588Immunoassays for lamotrigine
#5895-fluoro-uracil immunoassay
#590Modulators of pharmacokinetic properties of therapeutics
#591Method of modulating the activity of a nucleic acid molecule
#592Detection of blood plasma amygdalin of dissipating blood stasis botanical
#593Administering a therapeutic agent with more than one taggant
#594Detection of blood plasma schizadrin B of dissipating blood stasis botanical
#595Autophagy and phospholipidosis pathway assays
#596BRM EXPRESSION AND RELATED DIAGNOSTICS
#597APPARATUS FOR DETECTING DRUGS IN A BEVERAGE
#598Stabilized standards for busulfan immunoassay
#599Methods and systems for analyzing medication levels in a sample
#600Methods of optimizing drug therapeutic efficacy for treatment of immune-mediated gastrointestinal disorders